AZN: AstraZeneca PLC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AZN: AstraZeneca PLC

AZN 82.25

-0.4%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: EdR who wrote (22)	9/17/2002 10:19:46 AM
From: EdR	Read Replies (1) of 35

The FDA is holding a public meeting on IRESSA... <<snip>> ONCOLOGIC DRUGS ADVISORY COMMITTEE DATE: Sept. 24, 0830/1230 LOCATION: Holiday Inn, 8777 Georgia Ave., Silver Spring, MD CONTACT: Karen Templeton-Somers, 301-827-7001 The committee will discuss a new drug application for AstraZeneca Plc's <AZN.L> Iressa for the treatment of patients with locally advanced or metastatic non-small cell lung cancer who have previously received platinum-based chemotherapy.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next